SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-18-065508
Filing Date
2018-12-20
Accepted
2018-12-20 07:29:23
Documents
1
Period of Report
2018-12-18

Document Format Files

Seq Description Document Type Size
1 FORM 4 tv509477_form4.html 4  
1 FORM 4 tv509477_form4.xml 4 7092
  Complete submission text file 0001144204-18-065508.txt   9616
Mailing Address 20-22 BEDFORD ROW LONDON X0 WC1R 4JS
Business Address 20-22 BEDFORD ROW LONDON X0 WC1R 4JS 441-295-5950
Axovant Sciences Ltd. (Issuer) CIK: 0001636050 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 0331
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1 DEXCEL STREET OR AKIVA L3 30600000
Business Address 1 DEXCEL STREET OR AKIVA L3 30600000 972-4-636404
Dexxon Holdings Ltd. (Reporting) CIK: 0001636684 (see all company filings)

State of Incorp.: L3 | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-37418 | Film No.: 181244642

Mailing Address 1 DEXCEL STREET OR AKIVA L3 30600000
Business Address
Oren Dan (Reporting) CIK: 0001636701 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37418 | Film No.: 181244644

Mailing Address 1 DEXCEL STREET OR AKIVA L3 3060000
Business Address 1 DEXCEL STREET OR AKIVA L3 3060000 97246364040
Dexcel Pharma Technologies Ltd. (Reporting) CIK: 0001720007 (see all company filings)

State of Incorp.: L3 | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-37418 | Film No.: 181244643